Restoring Dystrophin via Exon Skipping Strategies AOC 1044 – Mark Stahl, MD (Avidity Biosciences) BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.) DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics) ED051 – Michelle Mellion, MD (PepGen, Inc.) ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics) SRP-5051 – Teji Singh, MD (Sarepta Therapeutics) WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 59:37 Research Row Breakout Session: Approved or on the Horizon – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 59:48 Research Row Breakout Session: Impacting Downstream – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 59:13 Research Row Breakout Session: Exon Skipping Strategies – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 37:48 Advancements in Cell & Gene Therapy – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 2:12:40 Gene Therapy Town Hall – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 34:56 Keynote: Change How You See, See How You Change – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 36:32 Keynote: Priorities or Finding Your “US” – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 18:50 Duchenne Landscape Now Research & Trials Progress – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings «1…45678…25»Page 6 of 25
by: Parent Project Muscular Dystrophy
